activity
20232026
most citedPharmacoNet: Accelerating Large-Scale Virtual Screening by Deep Pharmacophore Modeling

21 citations · 27 across the 8 of their papers we have counts for

collaborators

8 papers

q-bio.BM2026

Atom-level Protein Representation Learning Improves Protein Structure Prediction

Taewon Kim, Hyosoon Jang, Hyunjin Seo +6

Recent advances in generative modeling show that pretrained representations can improve generation as conditioning features or alignment targets. Motivated by this, we study protei…

cs.CL2026

On the limits and opportunities of AI reviewers: Reviewing the reviews of Nature-family papers with 45 expert scientists

Seungone Kim, Dongkeun Yoon, Kiril Gashteovski +55

With the advancement of AI capabilities, AI reviewers are beginning to be deployed in scientific peer review, yet their capability and credibility remain in question: many scientis…

cs.AI2026

Progressive Multi-Agent Reasoning for Biological Perturbation Prediction

Hyomin Kim, Sang-Yeon Hwang, Jaechang Lim +6

Predicting gene regulation responses to biological perturbations requires reasoning about underlying biological causalities. While large language models (LLMs) show promise for suc…

cs.LG2025★ 1 cited

Compositional Flows for 3D Molecule and Synthesis Pathway Co-design

Tony Shen, Seonghwan Seo, Ross Irwin +4

Many generative applications, such as synthesis-based 3D molecular design, involve constructing compositional objects with continuous features. Here, we introduce Compositional Gen…

q-bio.BM2024★ 4 cited

Generative Flows on Synthetic Pathway for Drug Design

Seonghwan Seo, Minsu Kim, Tony Shen +4

Generative models in drug discovery have recently gained attention as efficient alternatives to brute-force virtual screening. However, most existing models do not account for synt…

q-bio.BM2024

DeepBioisostere: Discovering Bioisosteres with Deep Learning for a Fine Control of Multiple Molecular Properties

Hyeongwoo Kim, Seokhyun Moon, Wonho Zhung +3

Optimizing molecular properties while preserving biological activity is a central challenge in drug design. Bioisosteric replacement, which substitutes a molecular fragment with a…

cs.LG2023★ 1 cited

TacoGFN: Target-conditioned GFlowNet for Structure-based Drug Design

Tony Shen, Seonghwan Seo, Grayson Lee +5

Searching the vast chemical space for drug-like molecules that bind with a protein pocket is a challenging task in drug discovery. Recently, structure-based generative models have…

q-bio.BM2023★ 21 cited

PharmacoNet: Accelerating Large-Scale Virtual Screening by Deep Pharmacophore Modeling

Seonghwan Seo, Woo Youn Kim

As the size of accessible compound libraries expands to over 10 billion, the need for more efficient structure-based virtual screening methods is emerging. Different pre-screening…